Home > Journals > Medicine > Bulletin du cancer > summary
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Bulletin du Cancer
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
Printable version

Gastric carcinomas


Bulletin du Cancer. Volume 88, Number 11, 1105-18, Novembre 2001, Synthèses

Résumé   Article gratuit  

Author(s) : Sophie Dominguez, Antoine Adenis

Summary : Although its declining incidence in most Western countries, gastric cancer remains a leading cause of cancer death. In France, it ranks second after colorectal cancer in terms of frequency. Chronic gastritis is the most frequent pathological condition that predispose to gastric cancer. One of the most important aetiological factor of gastric carcinogenesis is obviously the infection by Helicobacter pylori. Positive diagnosis of gastric cancer is made by upper gastrointestinal endoscopy combined with biopsies. Surgical resection is currently the only potentially curative treatment. However, the 5-year-survival rate after apparently curative surgical resection remains only 15% in Western populations. The studies on adjuvant treatment after surgical resection, have failed to demonstrate any improvement in overall or disease-free survival. Although promising in the locally advance setting, the pre-operative cytotoxic approach with or without radiation therapy remains experimental. In advanced disease the so-called ECF regimen results in delayed symptoms-free survival, increased survival (median: 9 months) and better quality of life.

Keywords : gastric carcinoma, epidemiology, prognostic factors, surgery, radiation therapy, chemotherapy

 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]